Does gastric atrophy C2 require long-term medication?

Chronic atrophic gastritis C2 typically requires long-term medication to control disease progression. If any abnormalities occur, timely medical consultation is recommended. Detailed analysis is as follows:

Gastric atrophy C2 refers to a pathological condition in which gastric mucosal atrophy extends upward along the lesser curvature of the antrum without involving the cardia. It represents a subtype of atrophic gastritis, typically classified as mild to moderate. Due to gastric mucosal damage and functional decline, long-term pharmacological treatment is necessary to suppress inflammation, promote mucosal repair, and prevent complications.

Long-term medication for gastric atrophy C2 helps suppress inflammation and promotes repair and regeneration of the gastric mucosa. It can also alleviate symptoms such as epigastric discomfort, loss of appetite, and heartburn that may occur with this condition. Additionally, persistent gastric mucosal injury may lead to complications such as gastric ulcers or gastrointestinal bleeding. Long-term medication can help prevent these complications and reduce the risk of disease progression.

Medications commonly used in long-term management of gastric atrophy C2 may include proton pump inhibitors, H2 receptor antagonists, and gastric mucosal protectants. Dosages and treatment duration must strictly follow medical advice. If symptoms improve and no new discomfort arises, gradual dose reduction or discontinuation of medication may be considered. However, this must be done under a physician's guidance to avoid disease recurrence or worsening.